198 results
8-K
EX-99.1
AWH
Aspira Women's Health Inc.
12 Aug 24
Aspira Women’s Health Reports Second Quarter 2024 Financial Results
4:12pm
and other factors that may cause such differences include the satisfaction of customary closing conditions related to the offering and the expected
8-K
EX-5.1
AWH
Aspira Women's Health Inc.
2 Aug 24
Entry into a Material Definitive Agreement
5:26pm
identified to our satisfaction, of:
a.the Registration Statement, all exhibits thereto and the Prospectus;
b.the Amended and Restated Certificate … of the Shares.
We have also examined originals or copies, certified or otherwise identified to our satisfaction, of such records of the Company
8-K
EX-1.1
AWH
Aspira Women's Health Inc.
2 Aug 24
Entry into a Material Definitive Agreement
5:26pm
by the Company of its obligations hereunder and to the continuing satisfaction of the additional conditions specified in Section 6 of this Agreement
424B5
AWH
Aspira Women's Health Inc.
2 Aug 24
Prospectus supplement for primary offering
5:26pm
of common stock would be entitled to share in our assets remaining after the payment of liabilities and the satisfaction of any liquidation … to or changes in the provisions relating to satisfaction and discharge of the indenture;
· additions to or changes in the provisions relating
8-K
EX-4.1
s4turcw4
31 Jul 24
Entry into a Material Definitive Agreement
7:57am
8-K
juu0er65ix662vsg11v
31 Jul 24
Entry into a Material Definitive Agreement
7:57am
8-K
EX-10.1
968rrycx hxa
31 Jul 24
Entry into a Material Definitive Agreement
7:57am
8-K
EX-99.1
q5x76rlv2bffi
29 Jul 24
Aspira Women’s Health Appoints Mr. John Ragard to its Board of Directors
4:04pm
424B3
8uwo0n0y3e fjbw7f5s
24 Jul 24
Prospectus supplement
6:11pm
8-K
EX-10.1
jjy54s7
2 Jul 24
Aspira Women’s Health Announces $1.935 Million Private Placement Equity Financing
9:16am
8-K
EX-99.1
6z2f hbujfks0knsk
2 Jul 24
Aspira Women’s Health Announces $1.935 Million Private Placement Equity Financing
9:16am
8-K
knhg z4tpccam3
2 Jul 24
Aspira Women’s Health Announces $1.935 Million Private Placement Equity Financing
9:16am
8-K
EX-4.1
x8frj8fwdhjs
2 Jul 24
Aspira Women’s Health Announces $1.935 Million Private Placement Equity Financing
9:16am
8-K
EX-99.1
eav 4pmy4icecptj8
14 Jun 24
Aspira Women’s Health Provides Commercial, Reimbursement and Cash Guidance Updates
4:00pm
8-K
EX-99.1
6i732
15 May 24
Aspira Women’s Health Reports First Quarter 2024 Financial Results
8:00am
DEFA14A
x8hpb6ptc 4b
9 May 24
Additional proxy soliciting materials
6:39pm
424B5
6ne5 kd57
26 Apr 24
Prospectus supplement for primary offering
5:29pm